BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:19 PM
 | 
Aug 30, 2012
 |  BC Extra  |  Company News

FDA approves linaclotide

FDA approved Linzess linaclotide from Forest Laboratories Inc. (NYSE:FRX) and Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) to treat chronic constipation and irritable bowel syndrome with constipation (IBS-C). The partners will co-commercialize Linzess in the U.S., with a launch planned for next quarter. The price will...

Read the full 201 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >